Does VENETOCLAX Cause Mobility decreased? 171 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 171 reports of Mobility decreased have been filed in association with VENETOCLAX (Venclexta). This represents 0.3% of all adverse event reports for VENETOCLAX.
171
Reports of Mobility decreased with VENETOCLAX
0.3%
of all VENETOCLAX reports
23
Deaths
117
Hospitalizations
How Dangerous Is Mobility decreased From VENETOCLAX?
Of the 171 reports, 23 (13.5%) resulted in death, 117 (68.4%) required hospitalization, and 2 (1.2%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VENETOCLAX. However, 171 reports have been filed with the FAERS database.
What Other Side Effects Does VENETOCLAX Cause?
Death (9,412)
Off label use (6,252)
Neutropenia (3,041)
Febrile neutropenia (2,663)
Platelet count decreased (2,367)
Pyrexia (2,351)
Pneumonia (2,300)
Fatigue (2,281)
Diarrhoea (2,082)
White blood cell count decreased (1,913)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which VENETOCLAX Alternatives Have Lower Mobility decreased Risk?
VENETOCLAX vs VENLAFAXINE
VENETOCLAX vs VENTAVIS
VENETOCLAX vs VENTOLIN
VENETOCLAX vs VENTOLIN HFA
VENETOCLAX vs VERAPAMIL